Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsOpinionWhy sporadic bans won’t fix the ‘irrational drugs’ problem

    Why sporadic bans won’t fix the ‘irrational drugs’ problem

    India’s fixed dose combination (FDC) problem is neither a new one, nor unknown to the regulators or the medical fraternity or the pharmaceutical industry. What’s missing is a concerted effort to eliminate bad actors

    R Srinivasan
    August 30, 2024 / 10:04 IST
    The pharmaceutical manufacturing sector has been opposing bans on FDCs tooth and nail, since such drugs are immensely profitable for them
    • PRO Panorama

      Moneycontrol Pro Panorama | Tech tensions

      Jan 5, 2026 / 03:36 PM IST

      For January 5 edition of Moneycontrol Pro Panorama: S Jaishankar’s diplomacy strengthens India-Bangladesh relations, India faces...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts